Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Juarez

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|January 27, 2026
Comparison of severe maternal morbidity between pregnancy with subclinical hypothyroidism and overt hypothyroidismLaurel S Aberle, Katherine E Bayard, Kimberly M Juarez, et al.
Communications Medicine|December 9, 2022
Predominant SARS-CoV-2 variant impacts accuracy when screening for infection using exhaled breath vaporMitchell M McCartney, Eva Borras, Dante E Rojas, et al.
Neuro-Oncology Advances|April 29, 2024
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancerTiffany M Juarez, Jaya M Gill, Annie Heng, et al.
Journal of Breath Research|July 25, 2023
Oxylipin concentration shift in exhaled breath condensate (EBC) of SARS-CoV-2 infected patientsEva Borras, Mitchell M McCartney, Dante E Rojas, et al.
Cancers|January 25, 2025
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma RecurrenceRafi Kabarriti, Shane Lloyd, James Jabalee, et al.
AIDS and Behavior|June 10, 2021
Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.SMadeline C Frost, Elsa W Sweek, Elizabeth J Austin, et al.
Oncoimmunology|November 22, 2024
Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomasSantosh Kesari, Alexandre Wojcinski, Sarabjot Pabla, et al.
Harm Reduction Journal|July 19, 2022
Responding to a surge in overdose deaths: perspectives from US syringe services programsMadeline C Frost, Elizabeth J Austin, Maria A Corcorran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Pilot Study of High-Dose Pemetrexed in Patients with Progressive ChordomaSantosh Kesari, Naveed Wagle, Jose A Carrillo, et al.
The International Journal on Drug Policy|August 17, 2022
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectivesElizabeth J Austin, Maria A Corcorran, Elsa S Briggs, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Acta Obstetricia Et Gynecologica Scandinavica|January 27, 2026
Comparison of severe maternal morbidity between pregnancy with subclinical hypothyroidism and overt hypothyroidismLaurel S Aberle, Katherine E Bayard, Kimberly M Juarez, et al.
Communications Medicine|December 9, 2022
Predominant SARS-CoV-2 variant impacts accuracy when screening for infection using exhaled breath vaporMitchell M McCartney, Eva Borras, Dante E Rojas, et al.
Neuro-Oncology Advances|April 29, 2024
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancerTiffany M Juarez, Jaya M Gill, Annie Heng, et al.
Journal of Breath Research|July 25, 2023
Oxylipin concentration shift in exhaled breath condensate (EBC) of SARS-CoV-2 infected patientsEva Borras, Mitchell M McCartney, Dante E Rojas, et al.
Cancers|January 25, 2025
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma RecurrenceRafi Kabarriti, Shane Lloyd, James Jabalee, et al.
AIDS and Behavior|June 10, 2021
Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.SMadeline C Frost, Elsa W Sweek, Elizabeth J Austin, et al.
Oncoimmunology|November 22, 2024
Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomasSantosh Kesari, Alexandre Wojcinski, Sarabjot Pabla, et al.
Harm Reduction Journal|July 19, 2022
Responding to a surge in overdose deaths: perspectives from US syringe services programsMadeline C Frost, Elizabeth J Austin, Maria A Corcorran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Pilot Study of High-Dose Pemetrexed in Patients with Progressive ChordomaSantosh Kesari, Naveed Wagle, Jose A Carrillo, et al.
The International Journal on Drug Policy|August 17, 2022
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectivesElizabeth J Austin, Maria A Corcorran, Elsa S Briggs, et al.
Pageof 11